EW
Edwards Lifesciences·NYSE
--
--(--)
--
--(--)
EW fundamentals
Edwards Lifesciences (EW) Revenue Breakdown: Q4 2025 Business & Regional Performance
Edwards Lifesciences (EW) reported total revenue of 1.57B USD in Q4 2025, with its core business segment Transcatheter Heart Valve Therapy contributing 83.84%. Regionally, United States remained the largest market, accounting for 57.79% of total revenue. Explore Edwards Lifesciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Edwards Lifesciences (EW) reported total revenue of 1.57B USD in Q4 2025, with its core business segment Transcatheter Heart Valve Therapy contributing 83.84%. Regionally, United States remained the largest market, accounting for 57.79% of total revenue. Explore Edwards Lifesciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for Edwards Lifesciences year over year?What factors drove the changes in Edwards Lifesciences's revenue and profit?What is Edwards Lifesciences's gross profit margin?What does Edwards Lifesciences do and what are its main business segments?Did Edwards Lifesciences beat or miss consensus estimates last quarter?What guidance did Edwards Lifesciences's management provide for the next earnings period?What were the key takeaways from Edwards Lifesciences’s earnings call?What is the market's earnings forecast for Edwards Lifesciences next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
